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Abstract
Background: The interactive effect between diabetes and impaired kidney function on cognitive impairment in
older adults has not yet been reported. The aim of this study was to investigate the association of diabetes and
impaired kidney function with cognitive impairment among Chinese older people living in a rural area.
Methods: This cross-sectional study included 1,358 participants (age ≥60 years; 60.5 % women) in the population-based
Confucius Hometown Aging Project in Shandong, China. Data on demographics, lifestyle factors, health history, use of
medications, global cognitive function, and kidney function were collected through structured interviews,
clinical examinations, and blood tests. We defined diabetes as a fasting plasma glucose level ≥7.0 mmol/l or
use of hypoglycemic agents, impaired kidney function as glomerular filtration rate estimated from cystatin C
(eGFRcys) <60 ml/min/1.73 m
2. Cognitive impairment was defined using the education-based cut-off scores
of Mini-Mental State Examination (MMSE). Data were analyzed using multiple general linear and logistic
regression models.
Results: Cognitive impairment was defined in 197 (14.5 %) persons. The multi-adjusted β coefficient of
MMSE score associated with diabetes was −0.06 (95 % confidence interval [CI], −0.16, 0.03); the corresponding figures
associated with eGFRcys <60, 60–89.9, and ≥90 ml/min/1.73 m
2 were −0.15 (−0.28, −0.02), −0.01 (−0.10, 0.08),
and 0 (reference) (Ptrend = 0.046), respectively. Diabetes and impaired kidney function showed an interactive
effect on cognitive impairment (Pinteraction = 0.02). Compared with individuals having neither diabetes nor
impaired kidney function, those with both conditions had a multi-adjusted odds ratio of 4.23 (95 % CI,
2.10–8.49) for cognitive impairment. The relative excess risk due to interaction was 2.74.
Conclusions: This study suggests that concurrent presence of diabetes and impaired kidney function is
associated with a substantial likelihood for cognitive impairment in older adults.
Keywords: Diabetes, Kidney function, Cognitive impairment, Aging, Population-based study
Background
In 2010, ~36 million people were living with dementia in
the world; the number was projected to nearly double every
20 years [1]. In China, the age-specific prevalence of de-
mentia had steadily increased during 1990–2010, and ~9.2
million people were affected by dementia in 2010 [2].
Furthermore, mild cognitive impairment affects ~21 % of
Chinese people aged 65 years or older, with the prevalence
being higher in rural than in urban residents [3]. Dementia
or cognitive impairment is the major cause of functional
dependence and institutionalization, which significantly
decreases quality of life and increases costs of social care.
Identifying modifiable risk factors for cognitive impairment
or dementia would foster the development of proper strat-
egies for intervention, thus reducing the individual and
societal burden of the most devastating mental disorders in
the aging society.
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Diabetes affects about one in five Chinese people aged
60 years or older [4, 5]. In the past decade, numerous
population-based studies have shown rather consistent
association of diabetes with cognitive impairment and
dementia [6, 7]. In addition, chronic kidney disease or
reduced kidney function is common among older people
[8]. Cystatin C, a marker of kidney function, is consid-
ered superior to serum creatine in the general popula-
tion of older people [9]. Evidence has emerged that
reduced kidney function, measured with markers of low
glomerular filtration rate, is associated with cognitive
impairment in older adults [10–12]. As diabetes is one
of the leading causes of chronic kidney disease, older
adults with both diabetes and reduced kidney function
may present substantial impairment in cognitive per-
formance. However, the potential interaction between
diabetes and impaired kidney function on cognitive im-
pairment in older adults has not yet been reported.
On the basis of previous research, we hypothesize that
diabetes and reduced kidney function can interact to
affect cognitive performance among older people, such
that older adults with both diabetes and impaired kidney
function would have substantially increased likelihood of
cognitive impairment compare to those with neither
condition. In this study, we seek to test this hypothesis
using data from a population-based study of Chinese
older people living in a rural community.
Methods
Study population
Participants were from the Confucius Hometown Aging
Project (CHAP). The aim of CHAP was to investigate
the role of vascular risk factors and atherosclerotic
mechanisms in aging and health among older people
(age ≥60 years) living in the Xing Long Zhuang commu-
nity nearby Qufu city (Hometown of Confucius) in
Shandong, China, as fully described elsewhere [5, 13]. In
brief, of the 1,743 eligible subjects who were invited to
participate in the survey in 2010–2011, 205 refused, lost
contact or died before the survey, and 180 had missing
data on fasting plasma glucose (FPG) (n = 17) or cystatin
C (n = 163). Thus, the analytical sample included 1,358
persons (77.9 % of all eligible subjects).
The CHAP protocols were reviewed and approved by
the ethics committee of Jining No. 1 People’s Hospital at
Jining Medical University, Shandong. Written informed
consent was obtained from all participants or, in the case
of cognitively impaired persons, from the next of kin.
Data collection and definition of measurements
Data were collected at the local Xing Long Zhuang
Hospital by trained physicians and nurses, following a
standard questionnaire that was developed from the
WHO STEPwise approach to Surveillance and the Study
on Global Ageing and Adult Health [5, 13, 14]. We
collected data on demographics, lifestyles (e.g., smoking,
alcohol consumption, and physical activity), medical
history (e.g., hypertension, diabetes, and stroke), and
use of medications (e.g., antihypertensive drugs and
hypoglycemic agents). Weight and height were mea-
sured with subjects wearing light clothes with no
shoes. Arterial blood pressure was measured twice on
the right arm using a sphygmomanometer in the sit-
ting position after at least a five-min rest, and the
mean of the two readings was used for analysis. We
defined and categorized various covariates as previ-
ously reported [5, 13]. Smoking status was defined as
“Yes” if the subjects consumed cigarette every day or
almost every day currently, otherwise the smoking sta-
tus was defined as “No”. Alcohol drinking was defined
as “No” if the subjects did not drink alcohol or drank
less than one time per month, and “Yes” if the subjects
drank alcohol one time per month or more in the last
year. Physical exercise was referred to as regularly
engaging moderate or heavy intensity exercise at least
3 times a week, and lasting for 20 min and over each
time. Hypertension was defined as blood pressure ≥140/
90 mmHg or current use of antihypertensive drugs. Body
mass index (BMI) was calculated as weight (kilograms) di-
vided by height (meters) squared. The 15-item Geriatric
Depression Scale (GDS-15) was used to assess depressive
symptoms, and the presence of high depressive symptoms
was defined as a GDS-15 score ≥5 [15].
Peripheral blood samples were taken after an overnight
fast. Total cholesterol, FPG, and serum cystatin C were
measured using the enzymatic methods by an Automatic
Biochemistry Analyzer (Olympus AU400, Japan) in the
certified hospital laboratory.
Diabetes was defined as FPG ≥7.0 mmol/l or current
use of hypoglycemic agents or insulin injection. Kid-
ney function was assessed by the cystatin C-based esti-
mated glomerular filtration rate (eGFRcys), which was
calculated following the equation proposed by the
Chronic Kidney Disease Epidemiology Collaboration
[16]: eGFRcys = 133 × (cystatin C/0.8)
−1.328 × 0.996age
(×0.932 if female) for cystatin C ≥0.8 mg/l;
133 × (cystatin C/0.8)−0.499 × 0.996age (×0.932 if female)
for cystatin C <0.8 mg/l. We first classified eGFRcys
into <60, 60–89.9, and ≥90 ml/min/1.73 m2, and then
we defined impaired or reduced kidney function as
eGFRcys <60 ml/min/1.73 m
2 [17].
Global cognitive functioning was assessed using a
Chinese version of the Mini-Mental State Examination
(MMSE) that had been validated among Chinese elderly
population [18]. Cognitive impairment was defined using
education-based cut-off points of MMSE [19]: 19/20 for
persons without formal education (illiteracy), 22/23 for
those with 1–6 years of education (primary school), and
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26/27 for those with more than 6 years of education
(middle school and higher).
Statistical analysis
Characteristics of study participants by cognitive impair-
ment were compared using t-test for continuous variable
and chi-square test for categorized variables. We used
general linear regression analysis to estimate the β coef-
ficient and 95 % confidence interval (CI) of MMSE score
associated with diabetes and impaired kidney function,
in which the MMSE score was transformed to –log (31-
MMSE score) owing to negatively skewed distribution of
the original MMSE score [20]. We employed logistic re-
gression models to estimate the odds ratio (OR) and 95 %
CI of cognitive impairment associated with diabetes and
impaired kidney function. We further assessed statistical
interaction between diabetes and kidney function on cog-
nitive performance by simultaneously including the two
independent variables and their cross-product term in a
same model. When a potential statistical interaction was
detected, stratified analysis was further conducted to as-
sess the joint effect of diabetes and impaired kidney func-
tion on cognitive performance, in which we categorized
the subjects into four groups, that is, having neither dia-
betes nor impaired kidney function (reference), having
diabetes alone, having impaired kidney function alone,
and having both conditions. Relative excess risk due to
interaction that reflects the departure from an additive
interactive effect on a relative risk scale was calculated
using the formula [21]: ORAB–ORA–ORB + 1. We re-
ported the main results from two models: model 1 was
adjusted for age, sex, and years of education, and model 2
was further adjusted for smoking, alcohol drinking, phys-
ical activity, BMI, hypertension, total cholesterol, stroke,
and depressive symptoms.
SAS 9.1.3 (SAS Institute Inc., Cary, NC, USA) was
used for all statistical analyses. We considered P < 0.05
to be statistically significant in a two-sided test.
Results
Characteristics of study participants
The mean age of the 1,358 participants was 68.6 years
(SD, 5.0) and 60.5 % were women. Compared with
subjects without cognitive impairment, those with
cognitive impairment were older, more likely to be fe-
male, illiterate, and physically inactive, less likely to
drink alcohol, and had a higher level of serum total
cholesterol, FPG, and a lower level of eGFRcys, as well
as higher prevalence of self-reported stroke, depres-
sive symptoms, and diabetes (Table 1).
Independent effect of diabetes and impaired kidney
function on cognitive impairment
When the transformed MMSE score was analyzed as a
continuous variable (outcome), diabetes was significantly
associated with a lower transformed MMSE score in
model 1, but the association was not significant when
additional variables were included in model 2 (Table 2).
There was a linear trend towards a decreasing level of
eGFRcys being associated with a decreasing transformed
MMSE score (multi-adjusted Ptrend = 0.046); the pres-
ence of impaired kidney function (eGFRcys <60 ml/min/
1.73 m2) was significantly associated with a lower trans-
formed MMSE score (Table 2).
When global cognitive functioning was analyzed as a
dichotomous variable (i.e., cognitive impairment, yes vs.
no) in the logistic model, diabetes was significantly asso-
ciated with an increased likelihood of cognitive impair-
ment, even in model 2 when all the examined potential
confounders were taken into account. However, there
was no significant linear trend for the association be-
tween levels of eGFRcys and likelihood of cognitive im-
pairment, although eGFRcys <60 ml/minute/1.73 m
2
tended to be associated with an elevated likelihood of
cognitive impairment (Table 2). When kidney function
was dichotomized into impaired vs. non-impaired (i.e.,
eGFRcys <60 vs. ≥60 ml/minute/1.73 m
2), the multi-
adjusted β coefficient (95 % CI) of the transformed
MMSE score associated with impaired kidney function
was −0.15 (−0.25, −0.04) (P = 0.007) in model 1 and
-0.14 (−0.25, −0.03) (P = 0.01) in model 2, whereas the
OR (95 % CI) of cognitive impairment associated with
impaired kidney function was 1.33 (0.90–1.96) (P = 0.15)
in model 1 and 1.40 (0.93–2.09) (P = 0.11) in model 2.
Joint impacts of diabetes and impaired kidney function
on cognitive impairment
When the transformed MMSE score was analyzed as a
continuous variable, there was no statistically significant
interaction between diabetes and impaired kidney func-
tion on global cognitive performance (Pinteraction = 0.19).
Stratified analysis by diabetes and impaired kidney func-
tion showed that the multi-adjusted β coefficient (95 %
CI) of the transformed MMSE score associated with hav-
ing neither diabetes nor impaired kidney function, hav-
ing only diabetes, having only impaired kidney function,
and having both diabetes and impaired kidney function
was 0 (reference), −0.04 (−0.14, 0.06), −0.11 (−0.23,
0.02), and −0.31 (−0.52, −0.10), respectively (Fig. 1a).
However, when cognitive function was examined as a di-
chotomous variable (i.e., cognitive impairment, yes vs.
no), there was a statistically significant interaction of
diabetes with impaired kidney function (eGFRcys <60 ml/
minute/1.73 m2) on cognitive impairment (Pinteraction =
0.02). Further analysis stratified by diabetes and impaired
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kidney function suggested that in comparison with per-
sons having neither diabetes nor impaired kidney func-
tion, the OR of having cognitive impairment for those
with both conditions was 4.23 (95 % CI, 2.10–8.49)
(Fig. 1b); the relative excess risk due to interaction was
2.74.
Similar results were obtained when subjects with a his-
tory of stroke (n = 86) were excluded from the analytical
sample (data not shown).
Discussion
This population-based study of Chinese elderly people
living in a rural community suggested that diabetes
and impaired kidney function were associated with
poor performance in global cognitive test or an increased
likelihood of cognitive impairment. In particular, this
study revealed an interactive effect between diabetes and
impaired kidney function on global cognitive impairment,
such that older individuals with both diabetes and im-
paired kidney function showed a substantially increased
likelihood of cognitive impairment.
The main effects of diabetes on cognitive impairment
or dementia in old adults are consistent with numerous
previous studies [6, 22–24]. Individuals with impaired
kidney function did perform worse in global cognitive
test compared to persons with normal kidney function,
which was in line with earlier studies [10, 11]. However,
when cognitive performance was dichotomized into
Table 2 Association of diabetes and eGFRcys with the Mini-Mental State Examination (MMSE) score and cognitive impairment
β coefficient (95 % CI) of MMSE scorea Odds ratio (95 % CI) of cognitive impairment
Factors Model 1b Model 2b Model 1b Model 2b
Diabetes −0.09 (−0.18,−0.0004) −0.06 (−0.16, 0.03) 1.81 (1.27, 2.60) 1.75 (1.20, 2.53)
eGFRcys, ml/min/1.73 m
2
≥90 0 (reference) 0 (reference) 1.00 (reference) 1.00 (reference)
60–89.9 −0.004 (−0.10, 0.09) −0.01 (−0.10, 0.08) 0.99 (0.64, 1.52) 0.98 (0.63, 1.52)
<60 −0.15 (−0.28, −0.02) −0.15 (−0.28, −0.02) 1.32 (0.78, 2.22) 1.37 (0.80, 2.35)
ptrend 0.039 0.046 0.27 0.23
CI confidence interval, eGFRcys cystatin C-based estimated glomerular filtration rate, MMSE Mini-Mental State Examination
aThe original MMSE score was transformed as –log (31-MMSE score)
bModel 1 was adjusted for age, sex, and years of education, and model 2 was further adjusted for smoking, physical activity, alcohol drinking, body mass index,
total cholesterol, hypertension, stroke, and depressive symptoms
Table 1 Characteristics of study participants by cognitive impairment
Cognitive impairment
Characteristics Total sample No Yes P-value
No. of subjects 1,358 1,161 197
Age (years), mean (SD) 68.6 (5.0) 68.23 (4.8) 70.90 (5.44) <0.001
Female, n (%) 821 (60.5) 671 (57.80) 150 (76.14) <0.001
Education level, n (%)
Illiterate 370 (27.25) 294 (25.32) 76 (38.58)
1–6 years 763 (56.19) 657 (56.59) 106 (53.81)
≥7 years 225 (16.57) 210 (18.09) 15 (7.61) <0.001
Current smoking, n (%) 185 (13.62) 164 (14.13) 21 (10.66) 0.190
Alcohol drinking, n (%) 276 (20.63) 250 (21.87) 26 (13.33) 0.007
Physical activity, n (%) 214 (15.76) 195 (16. 80) 19 (9.64) 0.01
Stroke, n (%) 86 (6.33) 59 (5.08) 27 (13.71) <0.001
Hypertension, n (%) 1,072 (78.94) 914 (78.73) 158 (80.20) 0.640
Total cholesterol (mmol/l), mean (SD) 5.33 (1.05) 5.29 (1.04) 5.53 (1.09) 0.004
BMI (kg/m2), mean (SD) 26.29 (3.76) 26.30 (3.68) 26.27 (4.20) 0.930
Depressive symptom, n (%) 271 (19.96) 213 (18.35) 58 (29.44) <0.001
Diabetes, n (%) 283 (20.84) 226 (19.47) 57 (28.93) 0.003
FPG (mmol/l), mean (SD) 5.70 (1.63) 5.66 (1.58) 6.02 (1.87) 0.004
eGFRcys (ml/min/1.73 m
2), mean (SD) 78.30 (20.06) 79.38 (20.02) 71.95 (19.18) <0.001
SD standard deviation, FPG fasting plasma glucose, BMI body mass index, eGFRcys cystatin C-based estimated glomerular filtration rate
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cognitive impairment vs. non-impairment, the associ-
ation between impaired kidney function and cognitive
impairment appeared to become less evident. This is
likely due to the fact that categorizing a continuous
outcome may reduce statistical power [25]. The key
finding of our study refers to the detection of an inter-
active effect between diabetes and impaired kidney
function on cognitive impairment, which may have im-
plications for understanding the pathophysiology of
cognitive consequence related to diabetes. Our study
indicates that the association of diabetes with cognitive
impairment is to some extent dependent on the pres-
ence of impairment in kidney function, such that dia-
betes was associated with cognitive impairment mainly
in the presence of impaired kidney function. This im-
plies that impaired or reduced kidney function may be
a critical pathophysiological basis for older people with
diabetes to manifest cognitive impairment or dementia.
Chronic kidney disease is one of the most common
complications of long-term diabetes. This is in line with
previous studies showing that long-term or severe dia-
betes is important in the development of cognitive
impairment and dementia [26, 27].
Glucose toxicity, inflammation, oxidative stress, insulin
resistance, blood–brain barrier disruption, and cerebral
macro- and microvascular disease associated with diabetes
are the well-established pathophysiological mechanisms
linking diabetes with cognitive impairment [7, 28]. Small
vessel diseases in the brain and kidney share common
causes or cardiometabolic risk factors such as diabetes and
hypertension. Thus, impaired kidney function due to glom-
erular small vessel disease has been suggested to correlate
Fig. 1 Joint impacts of diabetes and impaired kidney function on the transformed MMSE score (a) and global cognitive impairment (b). β
coefficients were derived from general linear regression model (a), and odds ratios from logistic regression model (b) while controlling for age,
sex, years of education, smoking, physical activity, alcohol drinking, body mass index, total cholesterol, hypertension, stroke, and depressive
symptoms. DM, diabetes mellitus; eGFRcys, cystatin C-based estimated glomerular filtration rate; MMSE, Mini-Mental State Examination.
*P < 0.01
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with subclinical cerebral microvascular disease in older
adults [29, 30], which, together with neuronal injury owing
to uremic toxins, could promote the development of
cognitive impairment and dementia [31]. The biological
mechanisms for the interactive effect between diabetes
and impaired kidney function on cognitive impairment
are not fully understood, but multiple pathways are
likely to be involved. First, diabetes and impaired
kidney function potentially share common mechanisms
leading to cognitive impairment such as inflammation,
peripheral vascular disease, and cardiovascular disease
[32]. Furthermore, the concurrent presence of diabetes
and impaired kidney function may indicate substantial
burden of cerebral small vessel disease, which might
considerably increase likelihood of having cognitive
impairment [29]. Finally, chronic kidney disease may
accelerate cognitive decline in patients with diabetes,
through pathophysiological processes such as anemia,
inflammation or oxidative stress [33, 34].
A major strength of this study refers to the population-
based design that targets older people living in a rural area
in China to whom very little attention has been paid by
researchers so far. Furthermore, we were able to control
for a broad range of health-related factors and health con-
ditions, as potential confounders, that were assessed from
epidemiological, clinical, and biological aspects by local
hospital staff. This study also has limitations. First, the
cross-sectional study does not allow us to determine the
temporal relationship of diabetes and impaired kidney
function to cognitive impairment. Further, selective
survival might affect the cross-sectional association, espe-
cially when diabetes, impaired kidney function, and cogni-
tive impairment are differentially associated with survival.
Third, we did not have a direct measure of glomerular
filtration rate, although the cystatin C-based eGFRcys, as
an approximation of glomerular filtration rate, is consid-
ered superior to that of the estimation from serum
creatinine [9]. Finally, we did not examine the interactive
effects of diabetes and impaired kidney function on
specific domains of cognitive function due to lack of the
relevant data.
Conclusions
In conclusion, this cross-sectional study reveals a
strong interactive effect between diabetes and impaired
kidney function on global cognitive impairment among
older adults. This implies that assessment of cognitive
function should be routinely recommended within geri-
atric settings for elderly patients with diabetes who also
show impairment in kidney function. Given the poten-
tial implications for clinical practice and public health
as well, further confirmation of this finding in longitu-
dinal studies is warranted.
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